Literature DB >> 20007675

Invited commentary: Human papillomavirus infection and risk of cervical precancer--using the right methods to answer the right questions.

Eduardo L Franco1, Joseph Tota.   

Abstract

Epidemiologists are well aware of the negative consequences of measurement error in exposure and outcome variables to their ability to detect putative causal associations. However, empirical proof that remedying the misclassification problem improves estimates of epidemiologic effect is seldom examined in detail. Of all areas in cancer epidemiology, perhaps the best example of the consequences of misclassification and of the steps taken to circumvent them was the pursuit, beginning in the mid-1980s, of the human papillomavirus (HPV) infection-cervical cancer association. The stakes were high: Had the wrong conclusions been reached epidemiologists would have been led astray in the search for competing hypotheses for the sexually transmissible agent causing cervical cancer or in ascribing to HPV infection a mere ancillary role among many lifestyle, hormonal, and environmental factors. The article by Castle et al. in this issue of the Journal (Am J Epidemiol. 2010;171(2):155-163) provides a detailed account of the joint influences of improved HPV and cervical precancer measurements in gradually unveiling the strong magnitude of the underlying association between viral exposure and cervical lesion risk. In this commentary, the authors extend the findings of Castle et al. by providing additional empirical evidence in support of their arguments.

Entities:  

Mesh:

Year:  2009        PMID: 20007675      PMCID: PMC2878105          DOI: 10.1093/aje/kwp392

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  25 in total

1.  Adding a test for human papillomavirus DNA to cervical-cancer screening.

Authors:  Thomas C Wright; Mark Schiffman
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

2.  Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group.

Authors: 
Journal:  J Natl Cancer Inst       Date:  2000-03-01       Impact factor: 13.506

3.  Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.

Authors:  N F Schlecht; S Kulaga; J Robitaille; S Ferreira; M Santos; R A Miyamura; E Duarte-Franco; T E Rohan; A Ferenczy; L L Villa; E L Franco
Journal:  JAMA       Date:  2001-12-26       Impact factor: 56.272

4.  Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group.

Authors:  E Franco; L Villa; T Rohan; A Ferenczy; M Petzl-Erler; G Matlashewski
Journal:  Rev Panam Salud Publica       Date:  1999-10

5.  Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas.

Authors:  D B Thomas; Q Qin; J Kuypers; N Kiviat; R L Ashley; A Koetsawang; R M Ray; S Koetsawang
Journal:  Am J Epidemiol       Date:  2001-04-15       Impact factor: 4.897

6.  Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica.

Authors:  R Herrero; A Hildesheim; C Bratti; M E Sherman; M Hutchinson; J Morales; I Balmaceda; M D Greenberg; M Alfaro; R D Burk; S Wacholder; M Plummer; M Schiffman
Journal:  J Natl Cancer Inst       Date:  2000-03-15       Impact factor: 13.506

7.  Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.

Authors:  D Solomon; M Schiffman; R Tarone
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

Review 8.  Statistical issues in human papillomavirus testing and screening.

Authors:  E L Franco
Journal:  Clin Lab Med       Date:  2000-06       Impact factor: 1.935

9.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

10.  HPV 16 DNA in normal and malignant cervical epithelium: implications for the aetiology and behaviour of cervical neoplasia.

Authors:  C A Meanwell; M F Cox; G Blackledge; N J Maitland
Journal:  Lancet       Date:  1987-03-28       Impact factor: 79.321

View more
  2 in total

1.  The road ahead for cervical cancer prevention and control.

Authors:  J E Tota; A V Ramana-Kumar; Z El-Khatib; E L Franco
Journal:  Curr Oncol       Date:  2014-04       Impact factor: 3.677

2.  Turning disciplinary knowledge into solutions.

Authors:  Sarah Gehlert
Journal:  J Adolesc Health       Date:  2013-05       Impact factor: 5.012

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.